Direkt zum Inhalt
Merck

Fbw7 dimerization determines the specificity and robustness of substrate degradation.

Genes & development (2013-12-04)
Markus Welcker, Elizabeth A Larimore, Jherek Swanger, Maria T Bengoechea-Alonso, Jonathan E Grim, Johan Ericsson, Ning Zheng, Bruce E Clurman
ZUSAMMENFASSUNG

The Fbw7 tumor suppressor targets a broad network of proteins for ubiquitylation. Here we show critical functions for Fbw7 dimerization in regulating the specificity and robustness of degradation. Dimerization enables Fbw7 to target substrates through concerted binding to two suboptimal and independent recognition sites. Accordingly, an endogenous dimerization-deficient Fbw7 mutation stabilizes suboptimal substrates. Dimerization increases Fbw7's robustness by preserving its function in the setting of mutations that disable Fbw7 monomers, thereby buffering against pathogenic mutations. Finally, dimerization regulates Fbw7 stability, and this likely involves Fbw7 trans-autoubiquitylation. Our study reveals novel functions of Fbw7 dimerization and an unanticipated complexity in substrate degradation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Tetramethylammoniumhydroxid Pentahydrat, ≥97%
Sigma-Aldrich
Tetramethylammoniumchlorid -Lösung, for molecular biology
Sigma-Aldrich
Tetramethylammoniumhydroxid Pentahydrat, ≥95.0% (T)
Sigma-Aldrich
Tetramethylammoniumiodid, 99%
Sigma-Aldrich
Tetramethylammoniumchlorid, reagent grade, ≥98%
Sigma-Aldrich
Tetramethylammoniumchlorid, BioUltra, for molecular biology, ≥99.0% (AT)
Sigma-Aldrich
Hydrochinidin, 95%
Supelco
Tetramethylammoniumchlorid, suitable for ion pair chromatography, LiChropur, ≥99.0% (AT)
Supelco
Tetramethylammoniumsulfat, suitable for ion pair chromatography, LiChropur, ≥99.0% (T)